SEC Form 4 · accession 0001140361-15-007862
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay Mazelsky
Officer — Executive Vice President
Period of report
Feb 14, 2015
Accepted (ET)
Feb 18, 2015 · 6:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 14, 2015 | M | 202 | $0.00 | A | 3,612 | D | |
| Common Stock | Feb 14, 2015 | M | 273 | $0.00 | A | 3,885 | D | |
| Common Stock | Feb 14, 2015 | F | 176 | $159.08 | D | 3,709 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $159.08 | Feb 14, 2015 | A | 13,424 | A | — | Feb 13, 2025 | Common Stock | 13,424 | 13,424 | D |
| Incentive Stock Option (right to buy)F3 | $159.08 | Feb 14, 2015 | A | 628 | A | — | Feb 13, 2025 | Common Stock | 628 | 628 | D |
| Restricted Stock UnitF4 | — | Feb 14, 2015 | A | 1,179 | A | — | — | Common Stock | 1,179 | 8,749 | D |
| Restricted Stock UnitF5 | — | Feb 14, 2015 | M | 202 | D | — | — | Common Stock | 202 | 8,547 | D |
| Restricted Stock UnitF6 | — | Feb 14, 2015 | M | 273 | D | — | — | Common Stock | 273 | 8,274 | D |
Explanation of responses
- F1Includes 44 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 12/31/2014.
- F2Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that becomes exercisable as to 2,811 shares on 02/14/2016 and 02/14/2017, 2,810 shares on 02/14/2018 and 02/14/2019, and the remaining 2,182 shares on 02/14/2020.
- F3Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests on the fifth anniversary date (02/14/2020) of the grant.
- F4Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2016) of the date of grant.
- F5Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2015) of the date of grant.
- F6Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2014) of the date of grant.